|
Journal of Lipid Research, Vol. 43, 205-214, February 2002
Copyright © 2002 by Lipid Research, Inc.
Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
Brett Garnera,
David A. Priestmana,
Roland Stockerb,
David J. Harveya,
Terry D. Buttersa, and
Frances M. Platta
a Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK
b Biochemistry Group, Heart Research Institute, Sydney, 2050 N.S.W., Australia
Correspondence to:
Frances M. Platt, To whom correspondence should be addressed., fran{at}glycob.ox.ac.uk (E-mail)
The apolipoprotein E gene knockout (apoE-/-) mouse develops atherosclerosis that shares many features of human atherosclerosis. Increased levels of glycosphingolipid (GSL) have been reported in human atherosclerotic lesions; however, GSL levels have not been studied in the apoE-/- mouse. Here we used HPLC methods to analyze serum and aortic GSL levels in apoE-/- and C57BL/6J control mice. The concentrations of glucosyl ceramide (GlcCer), lactosyl ceramide (LacCer), GalNAcß1-4Galß1-4Glc-Cer (GA2), and ceramide trihexoside (CTH) were increased by approximately 7-fold in the apoE-/- mouse serum compared with controls. The major serum ganglioside, N-glycolyl GalNAcß1-4[NeuNAc 2-3]Galß1-4Glc-Cer (N-glycolyl GM2), was increased in concentration by approximately 3-fold. A redistribution of GSLs from HDL to VLDL populations was also observed in the apoE-/- mice. These changes were accompanied by an increase in the levels of GSLs in the aortic sinus and arch of the apoE-/- mice. The spectrum of gangliosides present in the aortic tissues was more complex than that found in the lipoproteins, with the latter represented almost entirely by N-glycolyl GM2 and the former comprised of NeuNAc 2-3Galß1-4Glc-Cer (GM3), GM2, N-glycolyl GM2, GM1, GD3, and GD1a.
In conclusion, neutral GSL and ganglioside levels were increased in the serum and aortae of apoE-/- mice compared with controls, and this was associated with a preferential redistribution of GSL to the proatherogenic lipoprotein populations. The apoE-/- mouse therefore represents a useful model to study the potential role of GSL metabolism in atherogenesis. Garner, B., D. A. Priestman, R. Stocker, D. J. Harvey, T. D. Butters, and F. M. Platt. Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice. J. Lipid Res. 2002. 43: 205214.
Supplementary key words:
apoE gene knockout, ganglioside analysis, atherosclerosis

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. N. Glaros, W. S. Kim, K.-A. Rye, J. A. Shayman, and B. Garner
Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
J. Lipid Res.,
August 1, 2008;
49(8):
1677 - 1681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Glaros, W. S. Kim, C. M. Quinn, W. Jessup, K.-A. Rye, and B. Garner
Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice
J. Lipid Res.,
February 1, 2008;
49(2):
324 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR
J. Biol. Chem.,
July 1, 2005;
280(26):
24515 - 24523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. VanderLaan and C. A. Reardon
Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis
J. Lipid Res.,
May 1, 2005;
46(5):
829 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Bodary, Y. Shen, F. B. Vargas, X. Bi, K. A. Ostenso, S. Gu, J. A. Shayman, and D. T. Eitzman
{alpha}-Galactosidase A Deficiency Accelerates Atherosclerosis in Mice With Apolipoprotein E Deficiency
Circulation,
February 8, 2005;
111(5):
629 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Didion and F. M. Faraci
Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2005;
25(1):
90 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Major, M. T. Wilson, J. L. McCaleb, Y. Ru Su, A. K. Stanic, S. Joyce, L. Van Kaer, S. Fazio, and M. F. Linton
Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2004;
24(12):
2351 - 2357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Seo, T. Wang, H. Dressman, E. E. Herderick, E. S. Iversen, C. Dong, K. Vata, C. A. Milano, F. Rigat, J. Pittman, et al.
Gene Expression Phenotypes of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2004;
24(10):
1922 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gong, H. Wei, S. H. Chowdhury, and S. Chatterjee
Lactosylceramide recruits PKC{alpha}/{epsilon} and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells
PNAS,
April 27, 2004;
101(17):
6490 - 6495.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|